Can a simple blood test tell two forms of a clotting disorder apart?

NCT ID NCT07142239

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study looks at three blood markers — mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) — in people with antiphospholipid syndrome (APS), an autoimmune condition that raises the risk of blood clots and pregnancy complications. Researchers want to see whether these markers differ between primary APS (occurring alone) and secondary APS (occurring with another autoimmune disease like lupus). The goal is to find a simple, inexpensive way to help tell the two forms apart.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If clear differences emerge, these simple blood tests could help doctors distinguish between primary and secondary antiphospholipid syndrome more easily.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The markers may not differ enough to be useful in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • New Valley University

    RECRUITING

    Al Khārjah, Kharga Oasis, 72511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.